United Kingdom next
generation sequencing market is expected to register robust growth in the
forecast period, 2023-2027. Next
Generation Sequencing (NGS) refers to a technology that is commonly utilized to
determine the sequence of nucleotides in each DNA sample. It allows sequencing
of DNA or RNA in a less time and at an affordable cost. The continuous
technological advancements in sequencing procedures, increase in genome mapping
programs, and rise in drug discovery platforms demanding NGS technology.
Moreover, the elevating number of initiatives by government bodies for
large-scale genomic sequencing projects and emergence of cloud computing as a
potential data management service are driving the adoption of NGS products.
Enhancing reimbursement and regulatory scenario for next generation sequencing
based diagnostic tests is proving to be beneficial for the market growth. Favorable
funding scenario for genomics research across the United Kingdom will provide
lucrative growth opportunities to the leading market players. Development of
cost-effective next generation sequencing services and products for researchers
is expected to promote the overall market expansion in the forthcoming years.
Rise in Genome Mapping Programs is
Projected to Catalyze the Market Growth
The decreasing cost of sequencing has
allowed governments bodies across United Kingdom to involve genomic analysis as
a significant part of disease diagnosis and personalized medicine. Various
public genome research initiatives have been undertaken and enhancing focus on
genomics health futures mission for the improvement of research &
development activities. The extensive investments on R & D activities to
expand access to new research capabilities, clinical trials, and technologies
for betterment of healthcare sector which is acting as another growth-inducing
factor. The increase in genome mapping programs and extensive research
activities on personalized medicine has further augmented the
Extensive R&D activities for
Developing Novel Next Generation Sequencing Technologies Fuels the Market
Growth
The rising R&D activities for
producing therapies used in the treatment of genetic disorders will inflate the
need for next generation sequencing procedure over the analysis period. With
this, the elevating investments in R&D activities and high number of
studies related to treatment of genetic disorders among individuals is going to
support the growth of the market. Government bodies of developed economies such
as United Kingdom have launched numerous policies and initiated acts for
encouraging scientists and researchers to find solutions for treating chronic
and rare ailments. All these aforementioned factors are expected to drive the
market towards growth over the forecast period.
Escalating Demand for DNA Testing is
Estimated to Witness the Market Growth
The growing demand for DNA testing owing
to the continuous advancements in whole genome and exome sequencing procedures,
which offers faster results and cost effectives of the process as compared to
genotyping-based DNA microarray. This made manufacturers to launch the first
commercial sequencer, MinIon, utilizing Nanopore technology was introduced by
Oxford Nanopore Technologies. The sequencer assists in identifying DNA by
measuring the modifications in the electrical conductivity generated DNA
strands passed through biological pore. This technology allowed the detection
of outbreaks such as Zika virus. Various organizations worked on DNA sequencing
technologies for applied genomic testing, by introducing GENIUS sequencer,
which can sequence DNA anywhere.
DOWNLOAD FREE SAMPLE REPORT
Market Segmentation
The United
Kingdom next generation sequencing market is segmented into product,
technology, application, end user, regional
distribution, and competitive landscape. Based on product, the market is divided into consumables,
platforms, services. Based
on technology, the market is segmented into sequencing by synthesis, ion
semiconductor sequencing, sequencing by ligation, single molecule real time
sequencing, others. Based on application, the
market is divided into biomarkers & cancer, diagnostics, reproductive
health, personalized medicine, agriculture & animal research, others. Based on end user, the market is segmented into academic & clinical
research centers, pharmaceutical & biotechnology companies, hospitals &
clinics, others. To
analyze the market based on the region, the United Kingdom next generation sequencing
market is studied in major regions namely London, Southeast, East Anglia,
Scotland, Southwest, East Midlands, and Yorkshire & Humberside.
Market Players
Thermo Fischer Scientific, Inc., Illumina Cambridge
Limited, PerkinElmer (UK) Limited, Agilent Technologies UK Limited, Qiagen
Manchester Limited, Oxford Nanopore Technologies Limited, Roche Diagnostics
Limited, are the significant market players
operating in United Kingdom next generation sequencing market.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historic Data
|
2017 –
2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023
– 2027
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments covered
|
·
Product
·
Technology
·
Application
·
End User
|
|
Regional scope
|
London, Southeast, East Anglia, Scotland,
Southwest, East Midlands, and Yorkshire & Humberside
|
|
Key companies profiled
|
Thermo Fischer Scientific, Inc., Illumina Cambridge Limited,
PerkinElmer (UK) Limited, Agilent Technologies UK Limited, Qiagen Manchester
Limited, Oxford Nanopore Technologies Limited, Roche Diagnostics Limited
|
|
Customization scope
|
10%
free report customization with purchase. Addition or alteration to regional
& segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and
Excel through Email (We can also provide the editable version of the report
in PPT/Word format on special request)
|
Report Scope:
In this report, United Kingdom next
generation sequencing market has been segmented into following categories, in
addition to the industry trends which have also been detailed below:
·
United Kingdom Next Generation Sequencing
Market, By Product:
o Consumables
o Platforms
o Services
·
United Kingdom Next Generation
Sequencing Market, By Technology:
o Sequencing by Synthesis
o Ion Semiconductor Sequencing
o Sequencing by Ligation
o Single Molecule Real Time Sequencing
o Others
·
United Kingdom Next Generation
Sequencing Market, By Application:
o Biomarkers & Cancer
o Diagnostics
o Reproductive Health
o Personalized Medicine
o Agriculture & Animal Research
o Others
·
United Kingdom Next Generation
Sequencing Market, By End User:
o Academic & Clinical Research Centers
o Pharmaceutical & Biotechnology
Companies
o Hospitals & Clinics
o Others
·
United Kingdom Next Generation Sequencing
Market, By Region:
o
London
o
Southeast
o
East
Anglia
o
Scotland
o
Southwest
o
East
Midlands
o
Yorkshire
& Humberside
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in United Kingdom Next Generation
Sequencing market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company
Information
o Detailed analysis and profiling of
additional market players (up to five).
United Kingdom next generation sequencing market is an upcoming report to be
released soon. If you wish an early delivery of this report or want to confirm
the date of release, please contact us at [email protected]